1. Home
  2. PROC vs OKUR Comparison

PROC vs OKUR Comparison

Compare PROC & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROC
  • OKUR
  • Stock Information
  • Founded
  • PROC 1976
  • OKUR 2011
  • Country
  • PROC Luxembourg
  • OKUR United States
  • Employees
  • PROC N/A
  • OKUR N/A
  • Industry
  • PROC Biotechnology: Pharmaceutical Preparations
  • OKUR
  • Sector
  • PROC Health Care
  • OKUR
  • Exchange
  • PROC Nasdaq
  • OKUR NYSE
  • Market Cap
  • PROC 203.1M
  • OKUR 234.2M
  • IPO Year
  • PROC N/A
  • OKUR N/A
  • Fundamental
  • Price
  • PROC $1.10
  • OKUR $15.99
  • Analyst Decision
  • PROC
  • OKUR Strong Buy
  • Analyst Count
  • PROC 0
  • OKUR 2
  • Target Price
  • PROC N/A
  • OKUR $37.50
  • AVG Volume (30 Days)
  • PROC 68.7K
  • OKUR 58.1K
  • Earning Date
  • PROC 11-26-2024
  • OKUR 11-07-2024
  • Dividend Yield
  • PROC N/A
  • OKUR N/A
  • EPS Growth
  • PROC N/A
  • OKUR N/A
  • EPS
  • PROC 0.52
  • OKUR N/A
  • Revenue
  • PROC $414,096,000.00
  • OKUR N/A
  • Revenue This Year
  • PROC $5.54
  • OKUR N/A
  • Revenue Next Year
  • PROC $8.54
  • OKUR N/A
  • P/E Ratio
  • PROC $1.11
  • OKUR N/A
  • Revenue Growth
  • PROC N/A
  • OKUR N/A
  • 52 Week Low
  • PROC $0.50
  • OKUR $9.80
  • 52 Week High
  • PROC $4.95
  • OKUR $77.60
  • Technical
  • Relative Strength Index (RSI)
  • PROC 41.91
  • OKUR N/A
  • Support Level
  • PROC $0.50
  • OKUR N/A
  • Resistance Level
  • PROC $1.76
  • OKUR N/A
  • Average True Range (ATR)
  • PROC 0.18
  • OKUR 0.00
  • MACD
  • PROC -0.06
  • OKUR 0.00
  • Stochastic Oscillator
  • PROC 44.44
  • OKUR 0.00

About PROC Procaps Group S.A.

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

About OKUR ONKURE THERAPEUTICS INC

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Share on Social Networks: